Expedia: B2B Segment Upside

Here at the Lab, we are back to comment on Expedia (NASDAQ: EXPE ). In our coverage, we provided two updates on the company. In 2022, we were long with a comps analysis between Q2 2019 Vs. Q2 2022 numbers "Buy-side hedge professionals conducting fundamental, income oriented, long term analysis across sectors globally in developed markets. Please shoot us a message or leave a comment to discuss ideas.DISCLOSURE: All of our articles are a matter of opinion, informed as they might be, and must be treated as su ...